(BAS) BASF SE - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000BASF111
Stock: Chemicals, Materials, Coatings, Agriculture, Ingredients
Total Rating 40
Risk 84
Buy Signal -0.34
| Risk 5d forecast | |
|---|---|
| Volatility | 28.1% |
| Relative Tail Risk | -3.73% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.22 |
| Alpha | -15.97 |
| Character TTM | |
|---|---|
| Beta | 0.417 |
| Beta Downside | 0.722 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.19% |
| CAGR/Max DD | 0.25 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 133.1471
Description: BAS BASF SE March 05, 2026
BASF SE is a diversified chemical company with six operational segments. Its business model spans basic chemicals to specialized solutions for various industries.
The Chemicals segment focuses on petrochemicals and intermediates, foundational components in the chemical industry. The Materials segment supplies advanced materials, including polyamides and isocyanates, which are crucial for plastics and other industrial applications.
The Industrial Solutions segment provides additives and ingredients for diverse industrial uses, such as automotive and construction. The Surface Technologies segment offers catalysts and coatings, primarily serving the automotive sector and other chemical processes.
The Nutrition & Care segment develops ingredients for consumer products in areas like food, personal care, and pharmaceuticals. The Agricultural Solutions segment provides agricultural inputs, including seeds, crop protection products, and digital farming solutions, addressing global food production needs.
BASFs operations also include engineering, rental, leasing, and commodity trading. For a comprehensive financial analysis, further research on ValueRay is recommended.
Headlines to watch out for
- Global industrial production directly impacts chemical demand
- Energy and raw material price volatility compresses margins
- Agricultural commodity prices influence crop protection sales
- Regulatory changes in emissions and chemical use increase compliance costs
- Automotive sector demand drives surface technologies and materials revenue
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 1.62b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.79 > 1.0 |
| NWC/Revenue: 24.82% < 20% (prev 21.75%; Δ 3.07% < -1%) |
| CFO/TA 0.07 > 3% & CFO 5.61b > Net Income 1.62b |
| Net Debt (21.75b) to EBITDA (6.05b): 3.60 < 3 |
| Current Ratio: 1.93 > 1.5 & < 3 |
| Outstanding Shares: last quarter (897.0m) vs 12m ago 0.50% < -2% |
| Gross Margin: 24.86% > 18% (prev 0.26%; Δ 2.46k% > 0.5%) |
| Asset Turnover: 77.67% > 50% (prev 81.15%; Δ -3.48% > 0%) |
| Interest Coverage Ratio: 2.28 > 6 (EBITDA TTM 6.05b / Interest Expense TTM 1.08b) |
Altman Z'' 3.42
| A: 0.20 (Total Current Assets 31.68b - Total Current Liabilities 16.41b) / Total Assets 78.02b |
| B: 0.37 (Retained Earnings 28.82b / Total Assets 78.02b) |
| C: 0.03 (EBIT TTM 2.47b / Avg Total Assets 79.22b) |
| D: 0.69 (Book Value of Equity 30.06b / Total Liabilities 43.68b) |
| Altman-Z'' Score: 3.42 = A |
Beneish M -3.19
| DSRI: 0.87 (Receivables 10.09b/12.33b, Revenue 61.53b/65.26b) |
| GMI: 1.05 (GM 24.86% / 26.18%) |
| AQI: 0.98 (AQ_t 0.27 / AQ_t-1 0.27) |
| SGI: 0.94 (Revenue 61.53b / 65.26b) |
| TATA: -0.05 (NI 1.62b - CFO 5.61b) / TA 78.02b) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of BAS shares?
As of March 15, 2026, the stock is trading at EUR 46.31 with a total of 2,464,586 shares traded.
Over the past week, the price has changed by +6.80%, over one month by -5.34%, over three months by +9.27% and over the past year by -0.97%.
Over the past week, the price has changed by +6.80%, over one month by -5.34%, over three months by +9.27% and over the past year by -0.97%.
Is BAS a buy, sell or hold?
BASF SE has no consensus analysts rating.
What are the forecasts/targets for the BAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.8 | 7.5% |
| Analysts Target Price | - | - |
BAS Fundamental Data Overview March 15, 2026
Market Cap USD = 46.68b (40.40b EUR * 1.1554 EUR.USD)
P/E Trailing = 133.1471
P/E Forward = 21.5517
P/S = 0.6773
P/B = 1.2333
P/EG = 0.7543
Revenue TTM = 61.53b EUR
EBIT TTM = 2.47b EUR
EBITDA TTM = 6.05b EUR
Long Term Debt = 18.93b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 3.51b EUR (from shortTermDebt, last quarter)
Debt = 24.42b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.75b EUR (from netDebt column, last quarter)
Enterprise Value = 62.07b EUR (40.40b + Debt 24.42b - CCE 2.76b)
Interest Coverage Ratio = 2.28 (Ebit TTM 2.47b / Interest Expense TTM 1.08b)
EV/FCF = 46.21x (Enterprise Value 62.07b / FCF TTM 1.34b)
FCF Yield = 2.16% (FCF TTM 1.34b / Enterprise Value 62.07b)
FCF Margin = 2.18% (FCF TTM 1.34b / Revenue TTM 61.53b)
Net Margin = 2.63% (Net Income TTM 1.62b / Revenue TTM 61.53b)
Gross Margin = 24.86% ((Revenue TTM 61.53b - Cost of Revenue TTM 46.23b) / Revenue TTM)
Gross Margin QoQ = 22.14% (prev 22.06%)
Tobins Q-Ratio = 0.80 (Enterprise Value 62.07b / Total Assets 78.02b)
Interest Expense / Debt = 1.23% (Interest Expense 301.0m / Debt 24.42b)
Taxrate = 37.07% (907.0m / 2.45b)
NOPAT = 1.55b (EBIT 2.47b * (1 - 37.07%))
Current Ratio = 1.93 (Total Current Assets 31.68b / Total Current Liabilities 16.41b)
Debt / Equity = 0.74 (Debt 24.42b / totalStockholderEquity, last quarter 33.19b)
Debt / EBITDA = 3.60 (Net Debt 21.75b / EBITDA 6.05b)
Debt / FCF = 16.20 (Net Debt 21.75b / FCF TTM 1.34b)
Total Stockholder Equity = 33.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.04% (Net Income 1.62b / Total Assets 78.02b)
RoE = 4.82% (Net Income TTM 1.62b / Total Stockholder Equity 33.60b)
RoCE = 4.70% (EBIT 2.47b / Capital Employed (Equity 33.60b + L.T.Debt 18.93b))
RoIC = 2.70% (NOPAT 1.55b / Invested Capital 57.53b)
WACC = 4.94% (E(40.40b)/V(64.83b) * Re(7.45%) + D(24.42b)/V(64.83b) * Rd(1.23%) * (1-Tc(0.37)))
Discount Rate = 7.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.24%
[DCF] Terminal Value 83.08% ; FCFF base≈1.10b ; Y1≈840.1m ; Y5≈514.2m
[DCF] Fair Price = N/A (negative equity: EV 15.94b - Net Debt 21.75b = -5.81b; debt exceeds intrinsic value)
EPS Correlation: -12.58 | EPS CAGR: -32.45% | SUE: 0.29 | # QB: 0
Revenue Correlation: -88.75 | Revenue CAGR: -12.43% | SUE: -0.30 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.43 | Chg7d=+0.005 | Chg30d=-0.025 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=2.34 | Chg7d=-0.181 | Chg30d=-0.220 | Revisions Net=-6 | Growth EPS=+4.4% | Growth Revenue=+0.8%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=-0.175 | Chg30d=-0.165 | Revisions Net=-6 | Growth EPS=+31.0% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 7.9% - Earnings Yield 0.8%)
[Growth] Growth Spread = -14.4% (Analyst -7.2% - Implied 7.2%)
P/E Trailing = 133.1471
P/E Forward = 21.5517
P/S = 0.6773
P/B = 1.2333
P/EG = 0.7543
Revenue TTM = 61.53b EUR
EBIT TTM = 2.47b EUR
EBITDA TTM = 6.05b EUR
Long Term Debt = 18.93b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 3.51b EUR (from shortTermDebt, last quarter)
Debt = 24.42b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.75b EUR (from netDebt column, last quarter)
Enterprise Value = 62.07b EUR (40.40b + Debt 24.42b - CCE 2.76b)
Interest Coverage Ratio = 2.28 (Ebit TTM 2.47b / Interest Expense TTM 1.08b)
EV/FCF = 46.21x (Enterprise Value 62.07b / FCF TTM 1.34b)
FCF Yield = 2.16% (FCF TTM 1.34b / Enterprise Value 62.07b)
FCF Margin = 2.18% (FCF TTM 1.34b / Revenue TTM 61.53b)
Net Margin = 2.63% (Net Income TTM 1.62b / Revenue TTM 61.53b)
Gross Margin = 24.86% ((Revenue TTM 61.53b - Cost of Revenue TTM 46.23b) / Revenue TTM)
Gross Margin QoQ = 22.14% (prev 22.06%)
Tobins Q-Ratio = 0.80 (Enterprise Value 62.07b / Total Assets 78.02b)
Interest Expense / Debt = 1.23% (Interest Expense 301.0m / Debt 24.42b)
Taxrate = 37.07% (907.0m / 2.45b)
NOPAT = 1.55b (EBIT 2.47b * (1 - 37.07%))
Current Ratio = 1.93 (Total Current Assets 31.68b / Total Current Liabilities 16.41b)
Debt / Equity = 0.74 (Debt 24.42b / totalStockholderEquity, last quarter 33.19b)
Debt / EBITDA = 3.60 (Net Debt 21.75b / EBITDA 6.05b)
Debt / FCF = 16.20 (Net Debt 21.75b / FCF TTM 1.34b)
Total Stockholder Equity = 33.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.04% (Net Income 1.62b / Total Assets 78.02b)
RoE = 4.82% (Net Income TTM 1.62b / Total Stockholder Equity 33.60b)
RoCE = 4.70% (EBIT 2.47b / Capital Employed (Equity 33.60b + L.T.Debt 18.93b))
RoIC = 2.70% (NOPAT 1.55b / Invested Capital 57.53b)
WACC = 4.94% (E(40.40b)/V(64.83b) * Re(7.45%) + D(24.42b)/V(64.83b) * Rd(1.23%) * (1-Tc(0.37)))
Discount Rate = 7.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.24%
[DCF] Terminal Value 83.08% ; FCFF base≈1.10b ; Y1≈840.1m ; Y5≈514.2m
[DCF] Fair Price = N/A (negative equity: EV 15.94b - Net Debt 21.75b = -5.81b; debt exceeds intrinsic value)
EPS Correlation: -12.58 | EPS CAGR: -32.45% | SUE: 0.29 | # QB: 0
Revenue Correlation: -88.75 | Revenue CAGR: -12.43% | SUE: -0.30 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.43 | Chg7d=+0.005 | Chg30d=-0.025 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=2.34 | Chg7d=-0.181 | Chg30d=-0.220 | Revisions Net=-6 | Growth EPS=+4.4% | Growth Revenue=+0.8%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=-0.175 | Chg30d=-0.165 | Revisions Net=-6 | Growth EPS=+31.0% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 7.9% - Earnings Yield 0.8%)
[Growth] Growth Spread = -14.4% (Analyst -7.2% - Implied 7.2%)